Circulating ACE2+ exosomes in plasma from both healthy donors and patients who recovered from COVID-19 inhibited SARS-CoV-2 infection by blocking the binding of the viral S protein to its cellular receptor (71). The gene discussed is ACE2; the disease is COVID-19.